enign prostatic hyperplasia (BPH) is a histologic diagnosis showing glandular and stromal hyperplasia in the prostate. Its symptoms usually occur after the age of 40, and its prevalence reaches 50%-60% by the age of 60 (1). About 50% of men who have a histologic diagnosis of BPH have lower urinary tract symptoms including storage and voiding symptoms (2). Imaging plays an important role in evaluation of enlargement locations and nodules, estimation of prostatic volumes, and management of BPH patients. Ultrasonography (US) and magnetic resonance imaging (MRI) are used in evaluation of the prostate. US is the most common imaging modality in BPH patients, because it is relatively inexpensive and provides important information in most patients. Recently, MRI has been more commonly used in management of prostate cancer (3). Wasserman (4) described the US classification of BPH using findings on sagittal and axial images of transrectal US based on the pathologic classification (5). Following this, Wasserman et al. (6) implemented this classification to MRI. The classification for detecting BPH types is important, as patients with different BPH types may have different symptoms and treatment options.
zone (8) . PUGs are located posterior to the proximal prostatic urethra and include two groups: a superficial group opening into the lumen and a deep group draining the ducts into the urethra. TZ is located anterolateral to the proximal urethra and superior to the verumontanum.
The proximal prostatic urethra is surrounded by the internal sphincter, which is composed of the smooth muscles of the bladder neck. The distal membranous urethra is surrounded by the external urethral sphincter, which is responsible for continence in men. The external urethral sphincter includes two muscular layers; the outer layer composed of striated muscles, and the inner layer composed of smooth muscles (10) .
The anterior fibromuscular stroma, including fibromuscular extensions of the detrusor muscle, surrounds the prostate anterolaterally (11) . There is also a capsule-like structure composed of fibromuscular tissue (mostly smooth muscle), which surrounds the entire prostate. The term "capsule" is an anatomic misnomer as this is not a real capsule that can be separated from the prostatic stroma. However, this term has been colloquially used (10) .
Pathophysiology of benign prostatic hyperplasia
BPH includes glandular and stromal enlargements (12) . Glandular enlargement mainly leads to the enlargement in the size of the prostate and obstructive symptoms, known as the static effect. Stromal enlargement increases the resistance of the parenchyma, known as the dynamic effect (4). BPH is characterized by expansile nodules, which include the proliferation of stroma, newly formed glandular structures, or both of these (mixed type BPH nodule) (6) . BPH nodules can be seen as ranging from hypointense to hyperintense on T2-weighted images depending on the ratio of stromal to glandular components (7). On T2-weighted images, the tissues with higher water content appear hyperintense, while those with less water content appear hypointense. Thus, hyperintense appearance (Fig. 1 ) of a BPH nodule is caused by cystic ectasia and hyperplastic glandular components, which are filled with secretion, while hypointense appearance (Fig. 2) is caused by fibromuscular components (13) .
Enlargement in BPH patients occurs first in the PUGs in the fourth decade and then continues to the TZ, which is the main site of BPH (8) . Although BPH mainly develops in TZ and PUGs, it can also develop in the peripheral zone (14) . However, TZ enlargement typically compresses and decreases the volume of the peripheral zone in most BPH patients (6) .
Magnetic resonance imaging classification of benign prostatic hyperplasia
MRI has been more commonly used in management of prostate cancer due to its better contrast resolution and sensitivity (3) . Recent studies in the use of MRI for diagnosis of prostate cancer reported that MRI-based prostate volume-adjusted prostate-specific antigen (PSA) could improve the effectiveness of PSA in the diagnosis of prostate cancer, and MRI-US fusion biopsy could improve cancer detection in enlarged prostates (15, 16) . Although US has been mainly performed in patients with BPH, MRI could be performed in patients with BPH due to in-
Main points
• Benign prostatic hyperplasia (BPH) is a common condition in middle-aged and older men and may cause lower urinary tract symptoms which can affect the quality of life.
• We presented the types of BPH based on the magnetic resonance imaging (MRI) classification.
• The most common types of BPH were types 1 and 3 in the existing literature.
• MRI, with its superior soft tissue contrast resolution, is more advantageous than ultrasound in determination of stromal/glandular ratio and classification of BPH types which may potentially help in choosing optimal treatment. (4, 6) . BPH types on MRI are as follows: type 0, an equal to or less than 25 cm 3 prostate showing little or no zonal enlargement (Fig. 3) 
Bilateral transition zone enlargement
The TZ margins appear more clearly with the enlargement, and the enlargement leads to the compression of the outer muscle layer of the urethra into a fibrostromal pseudocapsule (the surgical capsule). Bilateral TZ enlargement is analogous to the enlargements of "right and left lateral lobes" in Randall's classification (5) and corresponds to type 1 in MRI classification (6) (Fig. 4) . Bilateral TZ enlargement and BPH nodules are best evaluated on axial and coronal MRI scans. Randall (5) described the region posterior to the proximal urethra as posterior commissural (median), and it is regarded as retrourethral in MRI classification (6) . Retrourethral enlargement arises from the deep PUGs. This type of enlargement may lead to bladder outlet obstruction by compressing the bladder and displacing the trigon superiorly. It is best evaluated on sagittal images due to the relationship between the trigon and retrourethral prostatic tissue.
Retrourethral enlargement
Retrourethral enlargement alone is regarded as type 2 in MRI classification (6) (Fig. 5) . Type 3 includes patients who exhibit both TZ and retrourethral enlargements (Fig. 6) . Types 1 and 3 are the most common types seen (5).
Pedunculated enlargement
Randall (5) 
Subtrigonal enlargement
An ectopic PUG enlargement may be seen in the subtrigonal region. Subtrigonal enlargement is usually oval-or roundshaped and limited to this region without any continuation inferiorly. This is a rare BPH type, and it is thought that this type may not usually lead to obstructive symptoms due to its relatively isolated location (4). This type is considered type 6 and is best evaluated on sagittal images (Fig. 9) .
Type 7 includes patients exhibiting other combinations of these enlargements.
Conclusion
BPH is a common condition in middle-aged and older men and may cause lower urinary tract symptoms that can affect the quality of life. MRI, with its superior soft tissue contrast resolution, is more advantageous than US in differentiating BPH from prostate cancer, estimation of zonal and entire prostatic volumes, detection of enlargement locations, and classification of BPH types which may potentially help in choosing the optimal treatment. Thus, MRI can be effectively used for management of BPH in diagnosis, treatment, and response to the treatment. a b Figure 9 . Sagittal T2-weighted image of a 54-year-old male with type 6 BPH shows subtrigonal enlargement (arrow) without marked displacement of trigon.
